» Articles » PMID: 26519481

Vitamin D Exposures Reported to US Poison Centers 2000-2014: Temporal Trends and Outcomes

Overview
Journal Hum Exp Toxicol
Publisher Sage Publications
Specialty Toxicology
Date 2015 Nov 1
PMID 26519481
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: There has been an increased use of vitamin D both by prescription and by the public as a widely available supplement. We evaluated 15 years of single-substance vitamin D exposures to US poison centers.

Methods: Retrospective analysis of data from the National Poison Data System (NPDS) to evaluate clinical effects, trends, and outcomes of exposures to vitamin D over the period January 1, 2000 through June 30, 2014. Cases were limited to exposures involving vitamin D as a single substance. Multiple vitamin products that may have included vitamin D were not included in this study.

Results: From 2000 through June 30, 2014, there were 25,397 human exposures to vitamin D reported to NPDS. There was a mean of 196 cases per year from 2000 to 2005, followed by a 1600% increase in exposures between 2005 and 2011 to a new annual mean of 4535 exposures per year. The mean and median ages were 23.4 years and 10 years, respectively. There were no fatalities, but five (0.02%) major effect outcomes. Serious medical outcomes (major or moderate outcome) were infrequent, ranging from 2 patients/year to 22 patients/year. Clinical effects were primarily gastrointestinal (0.7-1.5%) and mild neurological effects (0.2-0.4%). There was a decline in the percentage of patients treated in a health care facility and of patients with serious medical outcome.

Conclusion: Despite the enormous increase in number of exposures, there was not a significant increase in patients with a serious medical outcome. Rare severe outcomes may occur.

Citing Articles

Comparative Analyses of the Safety Profiles of Vitamin D Receptor Agonists: A Pharmacovigilance Study Based on the EudraVigilance Database.

Gall Z, Kolcsar M Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770528 PMC: 11677518. DOI: 10.3390/ph17121686.


Mini-Review on Vitamin D in Pediatric Population and its Role in Respiratory and Atopic Disorders.

Indolfi C, Klain A, Dinardo G, Decimo F, Marrapodi M, Licari A Mini Rev Med Chem. 2024; 24(15):1386-1394.

PMID: 38415448 DOI: 10.2174/0113895575284873240212045431.


Vitamin D supplementation in later life: a systematic review of efficacy and safety in movement disorders.

Homann C, Homann B, Ivanic G, Urbanic-Purkart T Front Aging Neurosci. 2024; 16:1333217.

PMID: 38343878 PMC: 10853433. DOI: 10.3389/fnagi.2024.1333217.


Safety Profile of Vitamin D in Italy: An Analysis of Spontaneous Reports of Adverse Reactions Related to Drugs and Food Supplements.

Maggini V, Crescioli G, Ippoliti I, Gallo E, Menniti-Ippolito F, Chiaravalloti A J Clin Med. 2023; 12(14).

PMID: 37510843 PMC: 10381134. DOI: 10.3390/jcm12144726.


Optimized vitamin D repletion with oral thin film cholecalciferol in patients undergoing stem cell transplant.

Bartlett A, Zhang G, Wallace G, McLean S, Myers K, Teusink-Cross A Blood Adv. 2023; 7(16):4555-4562.

PMID: 37285801 PMC: 10425684. DOI: 10.1182/bloodadvances.2023009855.